中东和非洲免疫测定试剂和设备市场，按产品（试剂和试剂盒和分析仪）、平台（化学发光免疫测定、荧光免疫测定、酶免疫测定、放射免疫测定等）、技术（酶联免疫吸附测定、快速检测、酶联免疫斑点、蛋白质印迹、免疫 PCR 等）、样本类型（唾液、尿液、血液等）、应用（传染病、肿瘤学和内分泌学、骨骼和矿物质疾病、心脏病学、血液学和血液筛查、自身免疫性疾病、毒理学、新生儿筛查和其他应用）、最终用户（医院、临床实验室、制药和生物技术公司、血库、研究和学术实验室等）、国家（沙特阿拉伯、南非、埃及、阿联酋、以色列和中东及非洲其他地区）行业趋势和预测到 2028 年。
市场分析与洞察：中东和非洲免疫测定试剂和设备市场
预计中东和非洲免疫测定试剂和设备市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场将以 3.7% 的复合年增长率增长，预计到 2028 年将达到 10.85 亿美元。在抗击 Covid-19 中免疫测定试剂和设备使用量的增加推动了免疫测定试剂和设备市场的发展。
免疫测定是在实验室中检测特定分子的测试。它主要取决于抗体附着在样本中存在的分子（抗原）的特定结构上的整体能力。抗体是在体内对抗原的存在作出反应而产生的。抗体存在于体液中，包括血液、尿液唾液、组织液和其他体液，只要在体内发现抗原，就会与抗原结合。由于抗体是针对分析物或抗原的独特三维结构而设计的，因此只会特异性地附着在特定结构上。一旦从血浆中提取出抗体，多克隆抗体和单克隆抗体就适合用作检测试剂，以在最少其他物质干预的情况下识别和追踪特定目标分子。免疫测定可用于对样本中存在的分析物进行定量和定性分析。
酶联免疫吸附试验 (ELISA) 是一种广泛使用的免疫测定法，用于检测目标抗原及其浓度。它广泛用于检测血液样本中是否存在 HIV 等病毒。酶联免疫吸附试验 (EIA) 是一种使用抗体来识别目标抗原的测试，其中抗体用标记酶标记，该标记酶会产生极少量的抗原，需要进行识别。放射免疫测定利用放射性同位素来识别目标抗原。在化学发光免疫测定中，酶将底物转化为反应产物。化学发光微粒免疫测定中使用的酶将底物转化为吸收光子而不是产生特定颜色的反应物质。免疫测定已成为实验室中常见且众所周知的方法，因为它可以快速轻松地产生可靠而准确的结果。
推动免疫测定试剂和设备市场增长的因素包括慢性病和传染病发病率上升、COVID-19 疫情的出现、免疫测定的广泛应用、医疗支出增加以及药物筛选测试的广泛使用。然而，免疫测定试剂盒和设备的高成本、免疫测定试剂盒和设备的产品召回、自身抗体和抗试剂抗体导致的不准确/错误结果可能会在未来几年抑制市场增长。
免疫测定试剂和设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和免疫测定试剂和设备市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
免疫测定试剂和设备市场范围和市场规模
中东和非洲免疫测定试剂和设备市场根据产品、平台、技术、样本类型、应用和最终用户进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品，中东和非洲免疫测定试剂和设备市场细分为试剂和试剂盒和分析仪。试剂和试剂盒细分为 ELISA 试剂和试剂盒、快速检测试剂和试剂盒、ELISPOT 试剂和试剂盒、蛋白质印迹试剂和试剂盒以及其他试剂和试剂盒。ELISA 试剂和试剂盒进一步细分为第一代 ELISA、第二代 ELISA、第三代 ELISA、第四代和第五代 ELISA。分析仪细分根据类型细分为开放式系统和封闭式系统。根据设备类型细分为台式和落地式。2021 年，试剂和试剂盒细分为主导，因为它在药物开发和疾病检测中的使用率更高。全世界越来越多的疾病需要进行适当的检测以进行进一步治疗，这些试剂盒和试剂在检测特定疾病方面发挥着重要作用。和免疫测定一样，抗原抗体反应也发生，因此需要适当的条件来形成反应，而免疫测定中使用的试剂可以提供这样的条件以获得准确的结果。由于在任何药物发现以及疾病检测中的使用率很高，试剂和试剂盒占据主导地位并不断增长。
- 根据平台，中东和非洲免疫测定试剂和设备市场细分为化学发光免疫测定、荧光免疫测定、酶免疫测定、放射免疫测定等。2021 年，酶免疫测定领域占据市场主导地位，因为它具有易于执行测试、结果准确等诸多优势。然而，化学发光免疫测定领域正在增长，因为它在疾病诊断中提供了更好的结果和高性能。由于操作简单、结果准确，化学发光免疫测定在未来可能会增长。除此之外，该产品成本低廉，因此它正成为许多生物技术和制药行业的首选。
- 根据技术，中东和非洲免疫测定试剂和设备市场细分为酶联免疫吸附测定、快速检测、酶联免疫斑点、蛋白质印迹、免疫 PCR 和其他技术。2021 年，酶联免疫吸附测定领域占据主导地位，因为它灵敏度高、操作简单，可为任何疾病检测或任何药物开发提供准确的结果。这是公司在任何药物发现过程中进行的传统免疫测定。然而，酶联免疫斑点正在增长，因为它可以快速分析大量样本，因为一次程序中要分析的样本数量很大，这将提供广泛的应用，因此它在未来可能会增长。
- 根据样本类型，中东和非洲免疫测定试剂和设备市场细分为唾液、尿液、血液和其他。2021 年，血液部分占据市场主导地位，因为可以从血液中轻松检测到抗原。即使是药物或疫苗的发现，研究人员也会将抗原剂注射到动物体内，然后进一步取出血液进行血液开发。
- 根据应用，中东和非洲免疫测定试剂和设备市场细分为传染病、肿瘤学和内分泌学、骨骼和矿物质疾病、心脏病学、血液学和血液筛查、自身免疫性疾病、毒理学、新生儿筛查和其他应用。2021 年，肿瘤学和内分泌学领域占主导地位，因为全球发病率高，可以通过免疫测定轻松检测出来。除了检测之外，各种制药公司还参与开发用于治疗疾病的药物。这些疾病可以通过使用免疫测定来开发。然而，心脏病学领域可能会增长，因为在治疗前必须进行检测的人群中，心脏相关疾病病例增加。
- 根据最终用户，中东和非洲免疫测定试剂和设备市场细分为医院、临床实验室、制药和生物技术公司、血库、研究和学术实验室等。2021 年，制药和生物技术公司部门占据市场主导地位，因为免疫测定在药物开发中的使用率很高。这些行业开展药物分析，例如疾病诊断、治疗药物监测、药物发现中的生物等效性研究等。与此同时，市场上越来越多的生物技术和制药公司引领免疫测定的高度适应，从而加速了市场的增长。
免疫测定试剂和设备市场国家级分析
对免疫测定试剂和设备市场进行了分析，并按上述国家、形式、包装、性质、种类、技术、分销渠道、最终用户和应用提供了市场规模信息。
免疫测定试剂和设备市场报告涵盖的国家包括沙特阿拉伯、南非、埃及、阿联酋、以色列以及中东和非洲的其他国家。
由于新冠疫情导致免疫测定试剂和设备的使用增加，预计沙特阿拉伯地区的产品细分市场将在 2021 年至 2028 年的预测期内以最高增长率增长。由于慢性病和传染病发病率上升，南非的产品细分市场在中东和非洲市场占据主导地位。由于免疫测定的广泛应用，埃及在中东和非洲市场的增长中处于领先地位，因为该国的多种细分市场占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
免疫测定试剂和设备领域主要参与者不断增加的战略投资正在推动免疫测定试剂和设备市场的增长。
免疫测定试剂和设备市场还为您提供每个国家特定市场增长的详细市场分析。此外，它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。
竞争格局和免疫测定试剂和设备市场份额分析
免疫测定试剂和设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对免疫测定试剂和设备市场的关注有关。
从事免疫测定试剂和设备业务的主要公司包括 F. Hoffmann-La Roche Ltd、Siemens、Randox Laboratories Ltd.、Abbott、Bio-Rad Laboratories, Inc.、Merck KGaA、Beckman Coulter, Inc.（Danaher 的子公司）、Sysmex Corporation、bioMérieux SA、Thermo Fisher Scientific, Inc.、BD、深圳迈瑞生物医学电子股份有限公司、DiaSorin SpA、Ortho Clinical Diagnostics、QIAGEN、Quidel Corporation、BioCheck, Inc.、Bio-Techne、PerkinElmer Inc.、Agilent Technologies, Inc.、Luminex Corporation、MESO SCALE DIAGNOSTICS, LLC 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的公司还签订了许多合同、协议和发布，这也加速了免疫测定试剂和设备市场的发展。
例如，
- 2021 年 5 月，Ortho Clinical Diagnostics 推出了首个定量 COVID-19 IgG 刺突抗体检测以及核衣壳抗体检测，以帮助区分抗体反应的原因。该产品有助于扩大客户群，因为 Ortho Clinical Diagnostics 是唯一一家为美国实验室提供定量检测和核衣壳检测相结合的公司。
- 2021 年 1 月，DiaSorin SpA 推出了 LIAISON SARS-CoV-2 TrimericS IgG 测试，用于测定体内存在的针对 SARS-CoV-2 的 IgG 抗体数量，以确定 COVID-19 疫苗的有效性。这款新产品帮助该公司在长期抗击 COVID-19 中发挥了重要作用。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在免疫测定试剂和设备市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
5.1 NEW PRODUCT LAUNCHES:
5.2 REGULATIONS FOR IMMUNOASSAY REAGENT AND DEVICE MARKET –
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF CHRONIC AND INFECTIOUS DISEASES
6.1.2 EMERGENCE OF COVID-19 PANDEMIC
6.1.3 WIDE APPLICATION OF IMMUNOASSAY
6.1.4 INCREASING HEALTHCARE EXPENDITURE
6.1.5 WIDE USE IN DRUG SCREENING TESTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF IMMUNOASSAY KITS AND DEVICES
6.2.2 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES
6.3 OPPORTUNITIES
6.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
6.3.2 STRATEGIC INITATIVES BY THE COMPANIES
6.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
6.4 CHALLENGES
6.4.1 AVAILABILITY OFALTERNATIVE TECHNOLOGIES
6.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
7 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 REAGENTS & KITS
7.2.1 ELISA REAGENTS & KITS
7.2.1.1 THIRD-GENERATION ELISA
7.2.1.2 FIFTH-GENERATION ELISA
7.2.1.3 FOURTH-GENERATION ELISA
7.2.1.4 FIRST-GENERATION ELISA
7.2.1.5 SECOND-GENERATION ELISA
7.2.2 ELISPOT REAGENTS & KITS
7.2.3 RAPID TEST REAGENTS & KITS
7.2.4 WESTERN BLOT REAGENTS & KITS
7.2.5 OTHER REAGENTS & KITS
7.3 ANALYZERS
7.3.1 BY TYPE
7.3.1.1 OPEN-ENDED SYSTEMS
7.3.1.2 CLOSED-ENDED SYSTEMS
7.3.2 BY DEVICE TYPE
7.3.2.1 BENCH-TOP
7.3.2.2 FLOOR STANDING
8 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 ENZYME IMMUNOASSAY
8.3 FLUORESCENCE IMMUNOASSAYS
8.4 CHEMILUMINESCENCE IMMUNOASSAYS
8.5 RADIOIMMUNOASSAYS
8.6 OTHERS
9 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE
9.1 OVERVIEW
9.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
9.3 ENZYME-LINKED IMMUNOSPOT
9.4 RAPID TESTS
9.5 WESTERN BLOTTING
9.6 IMMUNO-PCR
9.7 OTHER TECHNIQUES
10 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE
10.1 OVERVIEW
10.2 BLOOD
10.3 URINE
10.4 SALIVA
10.5 OTHERS
11 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY AND ENDOCRINOLOGY
11.3 HEMATOLOGY & BLOOD SCREENING
11.4 CARDIOLOGY
11.5 INFECTIOUS DISEASES
11.6 BONE & MINERAL DISORDERS
11.7 AUTOIMMUNE DISORDERS
11.8 TOXICOLOGY
11.9 NEONATAL SCREENING
11.1 OTHER APPLICATIONS
12 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.3 CLINICAL LABORATORIES
12.4 HOSPITALS
12.5 RESEARCH & ACADEMIC LABORATORIES
12.6 BLOOD BANKS
12.7 OTHERS
13 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY REGION
13.1 MIDDLE EAST & AFRICA
13.1.1 SAUDI ARABIA
13.1.2 SOUTH AFRICA
13.1.3 EGYPT
13.1.4 U.A.E.
13.1.5 ISRAEL
13.1.6 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 2.3 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 DIASORIN S.P.A
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 PERKINELMER INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 BIOMÉRIEUX SA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 BD
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BECKMAN COULTER, INC (A SUBSIDIARY OF DANAHER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIOCHECK, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BIO-TECHNE
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIO-RAD LABORATORIES, INC.
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 LUMINEX CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 MERCK KGAA
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 MESO SCALE DIAGNOSTICS, LLC
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 ORTHO CLINICAL DIAGNOSTICS
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 QIAGEN
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 QUIDEL CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENTS
15.18 RANDOX LABORATORIES LTD.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SIEMENS
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 SYSMEX CORPORATION
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENTS
15.22 THERMO FISHER SCIENTIFIC INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PORTFOLIO
15.22.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 COST OF ELISA KITS BY CELL SCIENCES, INC.
TABLE 2 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 61 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 62 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 63 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 SAUDI ARABIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 SOUTH AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 SOUTH AFRICA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 68 SOUTH AFRICA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 SOUTH AFRICA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 70 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 71 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 72 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 SOUTH AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 EGYPT ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 EGYPT ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 81 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 82 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 83 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 EGYPT IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 85 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 86 U.A.E. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 87 U.A.E. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 88 U.A.E. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 U.A.E. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 91 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 92 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 93 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 U.A.E. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 95 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 96 ISRAEL ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 ISRAEL ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2019-2028 (USD MILLION)
TABLE 98 ISRAEL REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 ISRAEL ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 101 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2019-2028 (USD MILLION)
TABLE 103 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 ISRAEL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 REST OF MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET AND GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 REAGENTS & KITS SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET
FIGURE 14 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2020
FIGURE 15 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2020
FIGURE 16 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2020
FIGURE 17 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2020
FIGURE 18 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2020
FIGURE 19 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2020
FIGURE 20 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2020)
FIGURE 21 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020)
FIGURE 22 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 23 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 24 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2021 & 2028)
FIGURE 25 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
